The frequency of CD57+CXCR3+CD8+ T cells was not correlated with treatment response in patients with CMML (Fig. 3G), which further illustrates the distinct immunologic profile of this disease. This evidence concerns the gene CXCR3 and chronic myelomonocytic leukemia.